Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Esco2 restrains pathological endothelial-mesenchymal transition through hidden isoform regulation in a Roberts syndrome model
Roy Jung, Sherin Saheera, Chinmay M. Trivedi
Roy Jung, Sherin Saheera, Chinmay M. Trivedi
View: Text | PDF
Research Article Cell biology Development Vascular biology

Esco2 restrains pathological endothelial-mesenchymal transition through hidden isoform regulation in a Roberts syndrome model

  • Text
  • PDF
Abstract

Roberts syndrome is caused by biallelic ESCO2 pathogenic variants, but the mechanisms linking ESCO2 loss to embryonic endothelial failure remain poorly defined. Endothelial cells must maintain identity and resist endothelial-mesenchymal transition (EndMT), yet conventional transcriptomics measures gene abundance rather than isoform composition. Here, using endothelial-specific Esco2 deletion in a mouse model relevant to Roberts syndrome, we show that Esco2 loss causes yolk sac vascular remodeling failure, pathological EndMT, diversion from hemogenic endothelial fate, hemogenic endothelial depletion, impaired hematopoietic output, and embryonic lethality. Short-read single-cell RNA-seq revealed broad endothelial reprogramming, whereas single-cell long-read isoform sequencing uncovered a hidden layer of isoform dysregulation that conventional gene-level analysis failed to resolve. Esco2-deficient endothelium exhibited transcriptome-wide isoform switching, disruption of a multi-tier splicing-factor network, and predicted broad loss or rewiring of protein-coding output. Chromatin occupancy profiling localized Esco2 to exonic regions near alternatively spliced loci, supporting a cotranscriptional route to spliceopathy. Whole-genome sequencing showed that local DNA variation was insufficient to explain these changes, supporting a predominantly posttranscriptional mechanism. These findings identify isoform control as a disease-relevant layer of endothelial identity maintenance in Roberts syndrome.

Authors

Roy Jung, Sherin Saheera, Chinmay M. Trivedi

×

Figure 1

Endothelial deletion of Esco2 disrupts yolk sac vascular remodeling and causes embryonic lethality.

Options: View larger image (or click on image) Download as PowerPoint
Endothelial deletion of Esco2 disrupts yolk sac vascular remodeling and ...
(A) Breeding and tamoxifen-induction strategy for endothelial Esco2 deletion. Esco2F/F females were crossed with Esco2F/+;Cdh5-CreERT2 males, and tamoxifen was administered at E7.5 and E8.5. Esco2F/F;Cdh5-CreERT2 embryos were recovered at Mendelian ratios at E9.5 (P = 0.69) and E10.5 (P = 0.95; mutants moribund), but not at E13.5 (0/21; P = 0.043; χ2 goodness-of-fit test). (B) Representative E10.5 embryos (top) and yolk sacs (bottom). Mutants show blood pooling (blue arrow), edema (white arrows), and loss of vascular patterning and caliber hierarchy, including large- (white arrows), medium- (red arrows), and small-diameter (yellow arrows) vessels. Loss of vascular patterning occurred in 3 of 3 mutants (100%) versus 0 of 3 controls (0%); blood pooling in 3 of 3 mutants (100%) versus 1 of 6 controls (17%); and edema in 1 of 3 mutants (33%) versus 0 of 6 controls (0%). Scale bars: 1,000 μm (top), 100 μm (bottom). (C) Breeding strategy and genotype distribution for Lyve1-Cre;Esco2 crosses. Esco2F/F;Lyve1-Cre pups were depleted at P0 (3 of 42, all born dead; P = 0.003; χ2 goodness-of-fit test). (D) Representative E16.5 mutants showing abnormal liver morphology (red arrow) and dilated sinusoids (black arrows). The liver phenotype occurred in 3 of 3 mutants (100%) versus 0 of 3 controls (0%) at E16.5 and in 3 of 3 mutants (100%) versus 0 of 3 controls (0%) at each of E12.5, E13.5, and E14.5. Scale bars: 1,000 μm (left), 500 μm (middle), 100 μm (right). H, heart; L, liver; T, thymus. (E) Representative E9.5 mutants appear grossly normal, but their yolk sacs lack vascular patterning and caliber hierarchy. The vascular phenotype occurred in 3 of 3 mutants (100%) versus 0 of 3 controls (0%). Scale bars: 1,000 μm (top), 500 μm (bottom).

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts